These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Catalytic mechanism of the primary human prostaglandin F2α synthase, aldo-keto reductase 1B1--prostaglandin D2 synthase activity in the absence of NADP(H). Nagata N; Kusakari Y; Fukunishi Y; Inoue T; Urade Y FEBS J; 2011 Apr; 278(8):1288-98. PubMed ID: 21306562 [TBL] [Abstract][Full Text] [Related]
3. Recent reports about enzymes related to the synthesis of prostaglandin (PG) F(2) (PGF(2α) and 9α, 11β-PGF(2)). Watanabe K J Biochem; 2011 Dec; 150(6):593-6. PubMed ID: 21926128 [TBL] [Abstract][Full Text] [Related]
4. Prostaglandin F2alpha formation from prostaglandin H2 by prostaglandin F synthase (PGFS): crystal structure of PGFS containing bimatoprost. Komoto J; Yamada T; Watanabe K; Woodward DF; Takusagawa F Biochemistry; 2006 Feb; 45(7):1987-96. PubMed ID: 16475787 [TBL] [Abstract][Full Text] [Related]
5. Aldo keto reductase 1B7 and prostaglandin F2alpha are regulators of adrenal endocrine functions. Lambert-Langlais S; Pointud JC; Lefrançois-Martinez AM; Volat F; Manin M; Coudoré F; Val P; Sahut-Barnola I; Ragazzon B; Louiset E; Delarue C; Lefebvre H; Urade Y; Martinez A PLoS One; 2009 Oct; 4(10):e7309. PubMed ID: 19809495 [TBL] [Abstract][Full Text] [Related]
7. Aldose reductases influence prostaglandin F2α levels and adipocyte differentiation in male mouse and human species. Pastel E; Pointud JC; Loubeau G; Dani C; Slim K; Martin G; Volat F; Sahut-Barnola I; Val P; Martinez A; Lefrançois-Martinez AM Endocrinology; 2015 May; 156(5):1671-84. PubMed ID: 25730106 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the prostaglandin F synthase activity of human and bovine aldo-keto reductases: AKR1A1s complement AKR1B1s as potent PGF synthases. Lacroix Pépin N; Chapdelaine P; Fortier MA Prostaglandins Other Lipid Mediat; 2013 Oct; 106():124-32. PubMed ID: 23747692 [TBL] [Abstract][Full Text] [Related]
10. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. O'connor T; Ireland LS; Harrison DJ; Hayes JD Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318 [TBL] [Abstract][Full Text] [Related]
11. The human aldose reductase AKR1B1 qualifies as the primary prostaglandin F synthase in the endometrium. Bresson E; Boucher-Kovalik S; Chapdelaine P; Madore E; Harvey N; Laberge PY; Leboeuf M; Fortier MA J Clin Endocrinol Metab; 2011 Jan; 96(1):210-9. PubMed ID: 20943776 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS. Koda N; Tsutsui Y; Niwa H; Ito S; Woodward DF; Watanabe K Arch Biochem Biophys; 2004 Apr; 424(2):128-36. PubMed ID: 15047184 [TBL] [Abstract][Full Text] [Related]
13. Identification, cloning and regulation of cDNA encoding aldo-keto reductase 1B7 in the adrenal gland of two Saharan rodents Meriones libycus (Libyan jird) and Gerbillus gerbillus (gerbil). Mataoui-Mazari H; Amirat Z; Khammar F; Martinez A Gen Comp Endocrinol; 2011 Dec; 174(3):292-300. PubMed ID: 21963864 [TBL] [Abstract][Full Text] [Related]
14. Kinetic studies of AKR1B10, human aldose reductase-like protein: endogenous substrates and inhibition by steroids. Endo S; Matsunaga T; Mamiya H; Ohta C; Soda M; Kitade Y; Tajima K; Zhao HT; El-Kabbani O; Hara A Arch Biochem Biophys; 2009 Jul; 487(1):1-9. PubMed ID: 19464995 [TBL] [Abstract][Full Text] [Related]
15. Prostaglandin F(2alpha) suppresses early phase of adipogenesis, but is not associated with osteoblastogenesis in mouse mesenchymal stem cells. Fujimori K; Ueno T; Amano F Prostaglandins Other Lipid Mediat; 2010 Sep; 93(1-2):52-9. PubMed ID: 20601070 [TBL] [Abstract][Full Text] [Related]
16. Generation of human endometrial knockout cell lines with the CRISPR/Cas9 system confirms the prostaglandin F2α synthase activity of aldo-ketoreductase 1B1. Lacroix Pépin N; Chapdelaine P; Rodriguez Y; Tremblay JP; Fortier MA Mol Hum Reprod; 2014 Jul; 20(7):650-63. PubMed ID: 24674991 [TBL] [Abstract][Full Text] [Related]
17. Human and rodent aldo-keto reductases from the AKR1B subfamily and their specificity with retinaldehyde. Ruiz FX; Moro A; Gallego O; Ardèvol A; Rovira C; Petrash JM; Parés X; Farrés J Chem Biol Interact; 2011 May; 191(1-3):199-205. PubMed ID: 21329680 [TBL] [Abstract][Full Text] [Related]
18. Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin. Bains OS; Grigliatti TA; Reid RE; Riggs KW J Pharmacol Exp Ther; 2010 Dec; 335(3):533-45. PubMed ID: 20837989 [TBL] [Abstract][Full Text] [Related]
19. Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. Crosas B; Hyndman DJ; Gallego O; Martras S; Parés X; Flynn TG; Farrés J Biochem J; 2003 Aug; 373(Pt 3):973-9. PubMed ID: 12732097 [TBL] [Abstract][Full Text] [Related]
20. Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitors. Penning TM; Steckelbroeck S; Bauman DR; Miller MW; Jin Y; Peehl DM; Fung KM; Lin HK Mol Cell Endocrinol; 2006 Mar; 248(1-2):182-91. PubMed ID: 16417966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]